Senior Director
Exo Therapeutics
North Grafton, Massachusetts, United States
Disclosure information not submitted.
A Novel Exosite Inhibitor that Selectively Reprograms TBK1-STING Pathway for Autoimmune Diseases
Wednesday, June 19, 2024
4:15 PM – 4:30 PM PT
